Company lists
The New Jersey edition · 2026

Life sciencescompanies in New Jersey

Drug development, genomics & research, medical devices, nutrition, startups and more: the companies building life sciences in New Jersey, with their founders, funding, team size and business models.

547 company profiles115 with recorded fundingNovember 2026 edition
New Jersey · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent life sciences business events in New Jersey

Funding, M&A, contract wins and launches involving 794 life sciences companies in New Jersey, last 24 months: 98 M&A deals · 74 funding rounds · 27 Contracts · 5 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

FundingRegistered Direct Offering

Outlook therapeutics

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of ONS-5010/Lytenava, announced a $5.0 million registered direct…

Investors GMS Ventures and Investments
Biopharmaceutical
M&AAcquisition · Completed

Abn amro investment solutions acquires Insmed

ABN Amro Investment Solutions acquired a new stake in Insmed, Inc. (NASDAQ:INSM - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The…

Biopharmaceutical
M&AAcquisition · Announced

Tevogen bio acquires Management Services Organization

Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent ('LoI') to evaluate a…

Healthcare
M&AAcquisition · Completed

Australiansuper acquires Insmed

AustralianSuper Pty Ltd acquired a new stake in Insmed, Inc. (NASDAQ:INSM – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm…

Biopharmaceutical
M&AAcquisition · Completed

Embecta acquires Owen mumford

Embecta announced it has completed its previously announced acquisition of Owen Mumford Holdings Limited, a privately held innovator and manufacturer of medical devices and drug delivery…

Medical devices and drug delivery technologies
M&AAcquisition · Announced

Eqt acquires Omniactive health technologies

Swedish private equity firm EQT has emerged as the sole contender to acquire Sanjaya Mariwala-promoted OmniActive Health Technologies, after the only competing bid for the nutraceuticals…

Nutraceuticals
M&AMerger · Pending

Kuva Acquisition Corp. acquires Lisata therapeutics

Lisata Therapeutics, Inc. Announces Amendment and Waiver to Merger Agreement with Kuva Labs Inc.

M&AAcquisition · Announced

Axtria acquires Conexus solutions

Axtria, a global provider of AI‑first data analytics solutions for the life sciences industry, announced the acquisition of Conexus Solutions, a technology and managed services partner…

Technology and managed services partner specializing in CRM transformation across the Veeva and Salesforce ecosystems
M&AAcquisition · Announced

Catheter Precision acquires Fly Flyte, Inc.

Catheter Precision, Inc. today announced it received shareholder approval on April 15 th of the definitive agreement to acquire Fly Flyte, Inc.

Aviation
FundingPublic offering

Celldex therapeutics

Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX ) today announced the closing of its previously announced underwritten public offering of 11,896,750 shares of its…

Biotechnology
FundingSeries A+

Origin

Origin has raised USD $30 million in a Series A+ funding round, bringing its total funding to more than USD $50 million within a year. The round was led by Notion Capital, which also…

Investors Notion capital, Felix capital, Acadian ventures, HSBC Innovation Banking UK
Benefits Technology
M&AAcquisition · Announced

Embecta acquires Owen mumford

Embecta Corp. (NASDAQ:EMBC) shares are up on Thursday after the company agreed to acquire Owen Mumford Holdings Limited. Deal Valued At Up To $200 Million Embecta values the acquisition…

Drug delivery systems
M&AAcquisition · Completed

Catheter Precision acquires Fly Flyte Inc.

Creatd Inc. has completed the sale of its remaining 80% equity stake in subsidiary Fly Flyte Inc. to Catheter Precision Inc., a company listed on the NYSE American exchange under the…

M&AAcquisition · Announced

Kuva Labs Inc. acquires Lisata therapeutics

Lisata Therapeutics, Inc. entered into a definitive agreement to be acquired by Kuva Labs Inc.

LaunchLabVantage CORTEX

Labvantage Solutions

LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence…

AI analytics and automation platform
FundingPrivate placement

Avalon globocare corp

Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it has entered into definitive agreements for the issuance and sale of 6,372,550 shares of its common stock … at a purchase price of…

Technology
M&AAcquisition · Announced

Unnamed strategic acquirer acquires Catheter Precision

Catheter Precision (NYSE:VTAK) announced today that it agreed to divest its atherectomy catheter technologies to an unnamed strategic acquirer.

M&AMerger · Completed

Ra Medical acquires Catheter Precision

The deal was initially announced in September 2022. Under the terms of the agreement, Catheter Precision became a wholly-owned subsidiary of Ra Medical with a focus on the cardiac…

Launch2026 U.S. Incentive Compensation Benchmarking Study

Axtria

Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the release of its sixth edition of the annual U.S. Incentive…

Benchmarking Study
Contract

Qilu pharmaceutical · client: Lisata therapeutics

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), today announced that it has mutually terminated the February 2021 Exclusive License and Collaboration Agreement with…

Pharmaceutical
M&AAcquisition · Announced

Kuva Labs acquires Lisata therapeutics

Lisata announced that it has entered into a binding term sheet to be acquired by Kuva Labs, Inc., whereby Kuva will commence a tender offer to purchase all of the outstanding shares of…

Pharmaceutical
M&AAcquisition · Announced

Kuva Labs, Inc. acquires Lisata therapeutics

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company ... today announced that it has entered into a binding term sheet to be…

Pharmaceuticals
M&AAcquisition · Announced

Campbell & CO Investment Adviser LLC acquires Adma biologics

Campbell & CO Investment Adviser LLC acquired a new stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the 3rd quarter, according to its most recent filing with the…

Biotechnology
M&AAcquisition · Announced

Cerity partners acquires Adma biologics

Cerity Partners LLC grew its holdings in ADMA Biologics by 1.8% in the 2nd quarter. Cerity Partners LLC now owns 48,572 shares of the biotechnology company’s stock valued at $884,000…

Biotechnology
M&AAcquisition · Announced

Amalgamated bank acquires Adma biologics

Amalgamated Bank grew its stake in ADMA Biologics by 0.8% in the 2nd quarter. Amalgamated Bank now owns 67,665 shares of the biotechnology company’s stock valued at $1,232,000 after…

Biotechnology
M&AAcquisition · Announced

New York State Teachers Retirement System acquires Adma biologics

New York State Teachers Retirement System boosted its holdings in shares of ADMA Biologics by 0.3% during the second quarter. New York State Teachers Retirement System now owns 222,461…

Biotechnology
M&AAcquisition · Announced

Quadrant capital acquires Adma biologics

Quadrant Capital Group LLC grew its position in shares of ADMA Biologics by 3.9% in the second quarter. Quadrant Capital Group LLC now owns 16,660 shares of the biotechnology company’s…

Biotechnology

Life sciences companies in New Jersey, by funding and team

Few life sciences companies in New Jersey publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 547 active companies.

Showing 25 of 50

Cell and gene therapy company creating treatments for genetic diseases

Rare diseases
US$663.15mSeries C · Dec 2019
26+36% 12 mo to Dec 2021LinkedIn · Jul 2026
Fee-for-service
11 yr2015
—No postings tracked

Provider of implantable device for treatment of chronic heart failure

Cardiac and vascular disorders
US$601.14mSeries F · Dec 2025
246-16% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce
28 yr1998
0none in 3 months

Developer of allogeneic cell therapies to treat multiple diseases

Oncology
US$290.00mSeries D · May 2018
142+0% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
10 yr2016
0none in 3 months

Developer of therapies for patients with cardiometabolic conditions

Cardiac and vascular disorders
US$287.00mSeries D · Jan 2026
62LinkedIn · Jul 2026
Physical commerce
7 yr2019
0none in 3 months

Developer of small molecule drugs for the treatment of rare diseases

Rare diseases
US$248.10mSeries J · May 2013
1,161-29% 12 mo to Dec 2023LinkedIn · Oct 2026
Physical commerce
28 yr1998
0none in 3 months · last posted Mar 2026

Restoring mutated p53 function to treat cancer with precision oncology

Oncology
US$236.00mSeries D · Aug 2020
69+2% 12 mo to Feb 2024LinkedIn · Oct 2026
Fee-for-service
13 yr2013
0none in 3 months

Provider of AI-powered data analytics and commercial solutions for life sciences

Healthcare it
US$198.74mSeries D · Apr 2021
3,650+28% 12 mo to Dec 2023LinkedIn · Oct 2026
Subscription
17 yr2009
6postings · last posted Oct 2026

Developer of non-invasive vagus nerve stimulation devices

Neurology
US$161.39mSeries B · Aug 2017
106-31% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
21 yr2005
0none in 3 months

Innovating therapies for unmet medical needs in hypertension, cardiorenal, and infectious diseases

Metabolic diseases
US$152.00mSeries A · Jan 2018
44LinkedIn · Jul 2026
Fee-for-service
19 yr2007
0none in 3 months

Developer of laser and robotic systems for surgical purposes

Surgical instruments
US$130.09mSeries F · Sep 2013
1+13% vs previous recordLinkedIn · Jul 2026
Physical commerce
26 yr2000
0none in 3 months

Developer of therapeutics to treat cancer

Oncology
US$130.00mSeries A · Jul 2024
39LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months

Innovating transformative treatments for ADHD, pain, and CNS disorders

Neurology
US$125.00mSeries B · Sep 2018
517-2% 12 mo to Dec 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
26 yr2000
0none in 3 months · last posted Jan 2026

Biotechnology firm improving vascular access by reducing surgical stenosis

Cardiac and vascular disorders
US$123.28mSeries C · Mar 2022
9+0% 12 mo to Dec 2021recorded Dec 2021
Physical commerce / Subscription
25 yr2001
0none in 3 months

Developer of minimally invasive products for musculoskeletal procedures

Orthopedics
US$110.00mSeries E · Aug 2007
3,555+27% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
23 yr2003
1postings · last posted Sep 2026

Developer of small molecule based therapeutics for the treatment of cancer, metabolic, and autoimmune disorders

Oncology
US$100.00mSeries A · Jun 2016
12+100% 12 mo to Dec 2017recorded Dec 2017
E-commerce - product / Physical commerce
10 yr2016
0none in 3 months

Developer of biologics for targeted immune regulation and restoration

Immunotherapy
US$100.00mSeries A · Aug 2024
—Not available
Physical commerce
2 yr2024
0none in 3 months

Developer of protein therapeutics to treat nephrology and urological conditions

Metabolic diseases
US$93.00mSeries C · Dec 2015
19-49% 12 mo to Dec 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
15 yr2011
0none in 3 months

Developer of small molecule therapeutics for ophthalmic disorders

Ophthalmology
US$86.00mSeries B · Apr 2019
4+0% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months

Developer of injectable non-opioid products for post-surgical pain control

Neurology
US$85.00mSeries A · Nov 2008
831-0% 12 mo to Dec 2023LinkedIn · Oct 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months · last posted Sep 2024

Developer of drugs to treat inflammation, HIV, liver disease and fibrosis

Gastroenterology
US$81.02mSeries B · Jan 2013
19+217% 12 mo to Feb 2016recorded Feb 2016
Physical commerce
25 yr2001
0none in 3 months

Modular segmental solutions (3D printing) for orthopedic procedures

Orthopedics
US$72.33mSeries C · May 2023
104LinkedIn · Jul 2026
Physical commerce
11 yr2015
0none in 3 months · last posted Sep 2025

Developer of therapeutics for the immuno-inflammatory conditions

Dermatology
US$62.89mSeries D · Dec 2018
20-70% 12 mo to Mar 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
16 yr2010
0none in 3 months

Developing glucan synthase inhibitors for the treatment of fungal infections.

Infectious diseases
US$62.65mSeries D · May 2012
52+52% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
27 yr1999
0none in 3 months · last posted Jun 2026

Developer of small molecule-based therapeutics for the treatment of CNS diseases

Neurology
US$57.06mSeries A · Apr 2018
150-12% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
21 yr2005
0none in 3 months · last posted Jul 2026

Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients

Ophthalmology
US$55.00mSeries E · Feb 2012
42LinkedIn · Jul 2026
E-commerce - product / Physical commerce
29 yr1997
0none in 3 months
50 of 547 companies shown here · the full list is on Radar
Fliar Radar

Explore all 547 life sciences companies in New Jersey on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in New Jersey on Radar
  • Every company, not just 50All 547 life sciences companies in New Jersey, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in New Jersey by what you are looking for

Discover life sciences companies in New Jersey working in drug development, genomics, medical devices and research. Compare New Jersey life sciences companies by their scientific focus.

7 ways to explore life sciences in New Jersey

Drug development and therapeutics companiesGenomics and research tools companiesMedical device and diagnostics companiesNutrition and nutraceutical companiesLife sciences startups in New JerseyLife sciences companies hiring in New Jersey

Drug development and therapeutics companies

Businesses developing therapies, medicines and clinical programs.

  1. Castle Creek Pharma

    Cell and gene therapy company creating treatments for genetic diseases

    Rare diseases
    See in list
  2. Celularity

    Developer of allogeneic cell therapies to treat multiple diseases

    Oncology
    See in list
  3. PTC Therapeutics

    Developer of small molecule drugs for the treatment of rare diseases

    Rare diseases
    See in list
  4. PMV Pharma

    Restoring mutated p53 function to treat cancer with precision oncology

    Oncology
    See in list
  5. ElectroCore

    Developer of non-invasive vagus nerve stimulation devices

    Neurology
    See in list

Genomics and research tools companies

Companies providing genomics, laboratory tools and research platforms.

  1. GenScript

    Provider of reagents and instruments for life sciences research

    Genomics
  2. WellGen

    Developer of medical foods using nutrigenomics

    Genomics
  3. Cancer Genetics

    Developer of cancer diagnostic solutions for personalized treatment

    Genomics
  4. CytoSite Bio

    Developer of immunotherapies for the treatment of cancer and autoimmune diseases

    Oncology
  5. Flyway Health

    Provider of AI agents for healthcare data analysis and strategy

    Life sciences tech

Medical device and diagnostics companies

Developers of clinical devices, diagnostics and treatment technologies.

  1. Impulse Dynamics

    Provider of implantable device for treatment of chronic heart failure

    Cardiac and vascular disorders
    See in list
  2. ElectroCore

    Developer of non-invasive vagus nerve stimulation devices

    Neurology
    See in list
  3. OmniGuide

    Developer of laser and robotic systems for surgical purposes

    Surgical instruments
    See in list
  4. Vascular Therapies

    Biotechnology firm improving vascular access by reducing surgical stenosis

    Cardiac and vascular disorders
    See in list
  5. Globus Medical

    Developer of minimally invasive products for musculoskeletal procedures

    Orthopedics
    See in list

Nutrition and nutraceutical companies

Companies developing supplements, nutrition products and medical foods.

  1. Oceans Omega

    Functional food company developing and marketing omega-3 concentrates

    Nutraceuticals tech
    See in list
  2. Cheers

    Manufacturer of dietary supplements to manage drinking side effects

    Nutraceuticals tech
  3. Healthycell

    Manufacturing and marketing branded cellular nutrition supplements

    Nutraceuticals tech
  4. Honed

    Provider of cellular diagnostic testing and personalized vitamins for optimized health

    Nutraceuticals tech
  5. AudiaCare

    Manufacturer of vitamin, protein and organic products

    Nutraceuticals tech

Life sciences startups in New Jersey

Recently founded life sciences companies in New Jersey.

  1. Navigator Medicines

    Developer of biologics for targeted immune regulation and restoration

    Immunotherapy
    See in list
  2. ArrePath

    Developer of anti-infectives to address antimicrobial resistance (AMR)

    Infectious diseases
    See in list
  3. BrainTemp

    Developer of non-invasive brain temperature monitoring systems

    Pediatrics
  4. Ensho Therapeutics

    Developer of oral therapies for patients with inflammatory bowel diseases

    Gastroenterology
  5. Flyway Health

    Provider of AI agents for healthcare data analysis and strategy

    Life sciences tech
58 companies in New Jersey

Life sciences companies hiring in New Jersey

Life sciences companies in New Jersey with current hiring activity.

  1. PTC Therapeutics

    Developer of small molecule drugs for the treatment of rare diseases

    Rare diseases
    See in list
  2. Axtria

    Provider of AI-powered data analytics and commercial solutions for life sciences

    Healthcare it
    See in list
  3. Tris Pharma

    Innovating transformative treatments for ADHD, pain, and CNS disorders

    Neurology
    See in list
  4. Globus Medical

    Developer of minimally invasive products for musculoskeletal procedures

    Orthopedics
    See in list
  5. Pacira

    Developer of injectable non-opioid products for post-surgical pain control

    Neurology
    See in list
20 companies in New Jersey

Public life sciences companies in New Jersey

Publicly listed life sciences companies in New Jersey.

  1. Celularity

    Developer of allogeneic cell therapies to treat multiple diseases

    Oncology
    See in list
  2. PTC Therapeutics

    Developer of small molecule drugs for the treatment of rare diseases

    Rare diseases
    See in list
  3. PMV Pharma

    Restoring mutated p53 function to treat cancer with precision oncology

    Oncology
    See in list
  4. ElectroCore

    Developer of non-invasive vagus nerve stimulation devices

    Neurology
    See in list
  5. Globus Medical

    Developer of minimally invasive products for musculoskeletal procedures

    Orthopedics
    See in list
58 companies in New Jersey
Mobile reach

Top 7 life sciences apps from New Jersey

The most-installed Android apps published by life sciences companies headquartered in New Jersey — 437K installs between them. 7 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 7
1

eAuditor Audits & Inspections

by Lyons Information Systems

Installs421K
Rating4.23567 ratings
Last updatedJun 2026
eAuditor Audits & Inspections screenshot 1eAuditor Audits & Inspections screenshot 2eAuditor Audits & Inspections screenshot 3eAuditor Audits & Inspections screenshot 4eAuditor Audits & Inspections screenshot 5eAuditor Audits & Inspections screenshot 6
2

Bausch + Lomb FitBetter™

by Bausch & Lomb

Installs12K
Rating—
Last updatedAug 2025
Bausch + Lomb FitBetter™ screenshot 1Bausch + Lomb FitBetter™ screenshot 2Bausch + Lomb FitBetter™ screenshot 3Bausch + Lomb FitBetter™ screenshot 4
3

NutraBio Brands

by Nutra Bio

Installs2K
Rating4.8264 ratings
Last updatedApr 2026
NutraBio Brands screenshot 1NutraBio Brands screenshot 2NutraBio Brands screenshot 3NutraBio Brands screenshot 4NutraBio Brands screenshot 5NutraBio Brands screenshot 6
4

PTC Events

by PTC Therapeutics

Installs830
Rating—
Last updatedMay 2026
PTC Events screenshot 1PTC Events screenshot 2PTC Events screenshot 3PTC Events screenshot 4PTC Events screenshot 5
5

MyJOGO

by JOGO

Installs174
Rating—
Last updatedSep 2025
MyJOGO screenshot 1MyJOGO screenshot 2MyJOGO screenshot 3MyJOGO screenshot 4MyJOGO screenshot 5MyJOGO screenshot 6
6

Insmed Events

by Insmed

Installs71
Rating—
Last updatedApr 2026
Insmed Events screenshot 1Insmed Events screenshot 2Insmed Events screenshot 3
7

Pacira Conventions & Meetings

by Pacira

Installs15
Rating—
Last updatedMay 2026
Pacira Conventions & Meetings screenshot 1Pacira Conventions & Meetings screenshot 2Pacira Conventions & Meetings screenshot 3Pacira Conventions & Meetings screenshot 4Pacira Conventions & Meetings screenshot 5
RadarBrowse every life sciences company in New Jersey on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how New Jersey compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, New Jersey98

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in New Jersey

76Acquisition
21Merger
1Announced

Most active acquirers

  1. Celgene8
  2. Globus medical6
  3. Bausch & lomb5
  4. Cantel medical4
  5. Embecta3

Most acquired or merged

  1. Adma biologics6
  2. Omniactive health technologies4
  3. Lisata therapeutics4
  4. Insmed3
  5. Owen mumford2

Each deal appears in the events strip at the top of the page.

Go deeper in the life sciences landscape reports:

Life Sciences Industry Landscape of the United States
Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of New Jersey maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of New Jersey

Life sciences funding in New Jersey

115 life sciences companies in New Jersey have recorded equity funding, US$5.33bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in New Jersey

Meet the people behind life sciences companies in New Jersey. 338 of 547 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore New Jersey life sciences companies by sub-sector

The most common specialisations among life sciences companies in New Jersey. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in New Jersey

176 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in New Jersey

Browse the Radar directory

Coming soon